Health
Johnson & Johnson COVID-19 vaccine candidate enters late-stage trials | News – Daily Hive
One shot, instead of two.
Pharma giant Johnson & Johnson has announced its COVID-19 vaccine candidate has entered the late-stage trials.
The pharmaceutical company said about 45,000 participants are currently enrolled in the trials, with interim data expected by the end of January 2021.
If the Johnson & Johnson vaccine candidate proves effective, the company says it will submit an emergency use authorization application to the US Food and Drug Administration (FDA) in February.
Johnson & Johnson’s study, named Ensemble, was…
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured
-
General21 hours agoGlobal Stocks flad as traders await Powell speech